Oncology Pharma and Kalos Therapeutics Expand Licensing Agreement for Exploring Kalos’s Anti-Cancer Lead Drug in Treating COVID-19

NEXT STORY
GSK and Vir Biotechnology enter collaboration to find coronavirus solutions
PREV STORY
IMMUNOMEDICS ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AND THE APPOINTMENT OF HAROUT SEMERJIAN AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Philips showcases integrated radiation oncology portfolio to provide a confident path to treatment at ASTRO 2019

author_avatar
NASDAQ Market News

SpringWorks Therapeutics Announces Dosing of First Patient in Phase 1b Combination Study Evaluating Nirogacestat and GlaxoSmithKline’s Belantamab Mafodotin for the Treatment of Relapsed or Refractory Multiple Myeloma

author_avatar
NASDAQ Market News

CNS Pharmaceuticals and Image Analysis Group Partner to Further the Development of Berubicin

author_avatar
NASDAQ Market News